Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic CD4(+) T cell phenotype and activation status in intermediate uveitis.

C C Murphy1, L Duncan, J V Forrester

  • 1Division of Ophthalmology, University of Bristol, UK.

The British Journal of Ophthalmology
|February 24, 2004
PubMed
Summary

Tumor necrosis factor-alpha (TNFalpha) is implicated in intermediate uveitis pathogenesis. Peripheral blood CD4(+) lymphocytes showed higher CD69 and TNFalpha expression in patients, suggesting potential for anti-TNF therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A window of opportunity: tear cytokine profiles in chronic ocular graft-versus-host disease.

Eye (London, England)·2026
Same author

Simplified flow cytometric quantification of human neutrophil extracellular traps (NETs).

Journal of inflammation (London, England)·2026
Same author

Self-reported chronic conditions and COVID-19 public health measures among Canadian adults: an analysis of the Canadian longitudinal study on aging.

Public health·2024
Same author

Uveitis Associated with Monogenic Autoinflammatory Syndromes in Children.

Ocular immunology and inflammation·2023
Same author

Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy.

Eye (London, England)·2023
Same author

Exploring a peer-based physical activity program in the community for adults with moderate-to-severe traumatic brain injury.

Brain injury·2023

Area of Science:

  • Immunology
  • Ophthalmology

Background:

  • Intermediate uveitis is an inflammatory eye condition.
  • Understanding the immune mechanisms is crucial for effective treatment.

Purpose of the Study:

  • To investigate peripheral blood lymphocyte phenotype in intermediate uveitis patients.
  • To analyze CD69, chemokine receptor, and cytokine expression.

Main Methods:

  • Flow cytometry and cytokine bead array used on 18 idiopathic and 6 sarcoid intermediate uveitis patients.
  • Compared peripheral blood CD4(+) T cell expression (CD69, CCR4, CCR5, CXCR3, IFNgamma, TNFalpha, IL-10) and cytokine production with healthy controls.

Main Results:

  • Significantly higher CD69 and TNFalpha expression on CD4(+) lymphocytes in intermediate uveitis patients versus controls.

Related Experiment Videos

  • Elevated IL-2:IL-5 and IFNgamma:IL-5 ratios in sarcoid intermediate uveitis patients.

    • Conclusions:

    • TNFalpha plays a role in intermediate uveitis pathogenesis, suggesting anti-TNF treatment potential.
    • Immune response in sarcoid intermediate uveitis shows Th1 polarization despite quiescent systemic disease.